巨大肾错构瘤行机器人辅助腹腔镜保留肾单位手术的单中心经验  

Single-center experience of robot-assisted laparoscopic nephron-sparing surgery for giant renal hamartoma

作　　者：陈心朋 韦飞 张琦[1] 刘锋[1] 杨运北 张大宏[1] Chen Xinpeng;Wei Fei;Zhang Qi;Liu Feng;Yang Yunbei;Zhang Dahong(Department of Urology,Zhejiang Provincial People′s Hospital,Hangzhou 310000,China;Graduate School of Bengbu Medical College,Bengbu 233000,China)

机构地区：[1]浙江省人民医院泌尿外科,杭州310000 [2]蚌埠医学院研究生院,蚌埠233000

出　　处：《中华医学杂志》2021年第25期1991-1993,共3页National Medical Journal of China

摘　　要：回顾性分析2014年10月至2020年1月浙江省人民医院22例巨大肾错构瘤患者接受机器人辅助腹腔镜保留肾单位手术治疗的临床资料。22例患者均顺利完成手术,手术时间为(179±34)min,肾动脉阻断时间为(19.8±2.5)min,术中出血量为(117±62)ml,术后住院时间为(9.0±1.5)d。术后病理均证实为肾血管平滑肌脂肪瘤;无尿漏、术后出血等并发症。术后电话随访6~52个月,手术侧均无肿瘤复发。The clinical data of 22 patients with giant renal hamartoma in Zhejiang Provincial People′s Hospital who underwent robot-assisted laparoscopic nephron-sparing surgery from October 2014 to January 2020 were retrospectively analyzed.All the patients successfully completed the operation.The operation time and renal artery occlusion time was(179±34)min and(19.8±2.5)min,respectively.The intraoperative blood loss was(117±62)ml,and the postoperative hospital stay was(9.0±1.5)d.All cases were confirmed as renal angiomyolipoma by postoperative pathology.No urine leakage,postoperative bleeding and other complications occurred.Postoperative telephone follow-up was performed for 6 to 52 months,and no tumor recurrence on the surgical side was reported.

关 键 词：错构瘤 机器人 腹腔镜 

分 类 号：R737.11[医药卫生—肿瘤]